We are Making Flow Cytometry more Accessible

Discover the Flow Cytometry Learning Center

Seize the cfDNA

Today’s the Day to Accelerate Your Liquid Biopsy Research

Request Your Free Apostle MiniMax Kit

Cell Sorting is Complex, but your Sorter doesn't have to be

Here's the CytoFLEX SRT Benchtop Cell Sorter

Automated Bioreactor Sample Delivery to the Vi-CELL BLU Cell Viability Analyzer

See how it works

Cell Line Development Without Manual Pipetting?

CELL-A-BRATE!

Increase your hits by automating your cell line development

The Beckman Coulter Life Sciences Difference

Beckman Coulter's commitment to your research dates back to our origin in 1935. For more than 80 years, we have been a trusted partner for laboratory professionals, helping to advance scientific research and patient care. Beckman Coulter Life Sciences and Beckman.com is a global resource for millions of life science researchers, industrial and environmental technicians, and pharmaceutical and biomedical scientists.

Learn more

Latest news & updates

Press Release

Beckman Coulter Life Sciences Completes First Phase of Colorado Research and Development Hub with Grand Opening of $10 Million Loveland Offices

LOVELAND, CO – (January 19, 2023) – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, further strengthens its commitment to the greater Loveland, Colorado community with the completion of the first phase of its new research and development hub.

Read more
Press Release

Beckman Coulter Life Sciences Accelerates Next Generation Sequencing by Launching the Biomek NGeniuS Next Generation Library Prep System

Indianapolis, IN – (June 28, 2022) Beckman Coulter Life Sciences accelerates next generation sequencing by launching the Biomek NGeniuS Next Generation Library Prep System, reducing errors and hands-on-time through automation.

Read more
Press Release

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

INDIANAPOLIS – (October 31, 2022) – More companies around the world continue turning to Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, for their next generation sequencing (NGS) needs with the Biomek NGeniuS System. The company continues building a robust demonstrated application library as it announces an application development agreement with Pillar Biosciences, which specializes in developing and commercializing IVD & RUO NGS testing solutions that help research to optimize selection of precision therapies for cancer patients, from tumor profiling to therapy selection, and recurrence monitoring.  

Read more